Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;19(7):3203-3209.
doi: 10.1002/alz.12985. Epub 2023 Feb 15.

What would a population-level approach to dementia risk reduction look like, and how would it work?

Affiliations

What would a population-level approach to dementia risk reduction look like, and how would it work?

Sebastian Walsh et al. Alzheimers Dement. 2023 Jul.

Abstract

Dementia is a leading global public health challenge. Prevention approaches have traditionally focused on individual-level strategies. However, such approaches have limited potential, particularly for resource-constrained populations in which exposure to risk factors is greatest, and exposure to protective factors is lowest. A population-level approach to dementia risk reduction is therefore essential to meet the scale of the challenge and to tackle global inequalities in risk and incidence of disease. Such approaches can be highly cost effective. In this viewpoint article, we describe what such an approach should look like, barriers and facilitators to success, and how we should go about achieving it. We include 10 strategic goals to achieve population-level dementia risk reduction and protection enhancement, targeted at researchers, professionals, funders, science communicators, governments, businesses, and policy makers. If we are to significantly reduce the prevalence of dementia there must be increased emphasis on population-level approaches. HIGHLIGHTS: Dementia risk reduction is a global public health priority Population-level approaches change societal conditions to make them less conducive to dementia's modifiable risk factors, and increase exposure to protective factors. Urgent development of population-level approaches is required to reduce the prevalence of, and inequalities in, dementia Action is required from researchers, governments and business, funders, public health professionals, and science communicators.

Keywords: dementia; public health; risk reduction.

PubMed Disclaimer

Comment in

References

REFERENCES

    1. Prince M. World Alzheimer Report 2015: The Global Impact of Dementia | Alzheimer's Disease International. World Alzheimer's Report. 2015.
    1. Walsh S, King E, Brayne C. France removes state funding for dementia drugs. BMJ. 2019;367:l6930. doi: 10.1136/bmj.l6930
    1. Loy C, Schneider L. Galantamine for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst Rev. 2006;2006(1):CD001747. doi: 10.1002/14651858.CD001747.pub3
    1. Birks JS, Chong LY, Grimley Evans J. Rivastigmine for Alzheimer's disease. Cochrane Database Syst Rev. 2015(9):CD001191. doi: 10.1002/14651858.CD001191.pub4
    1. Birks JS, Harvey RJ. Donepezil for dementia due to Alzheimer's disease. Cochrane Database Syst Rev. 2018;6(6):CD001190. doi: 10.1002/14651858.CD001190.pub3

LinkOut - more resources